Ligand validation:7DOA

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

EPE is a Ligand Of Interest in 7DOA designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7DOA_EPE_A_401	51%	12%	0.167	0.92	2.13	1.99	1	7	1	0	100%	1
7DOA_EPE_B_402	45%	13%	0.21	0.943	1.95	2.02	1	7	0	0	100%	1
7DOA_EPE_B_401	14%	14%	0.268	0.82	2	1.86	3	6	2	0	100%	1
8JFV_EPE_A_403	41%	49%	0.152	0.864	0.6	1.36	-	2	0	0	100%	1
8JFF_EPE_A_401	26%	55%	0.224	0.865	0.58	1.16	-	2	0	0	100%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
1CZB_EPE_A_300	100%	65%	0.04	0.991	0.69	0.67	-	-	0	0	100%	1
8VCQ_EPE_F_201	100%	60%	0.044	0.984	0.85	0.68	1	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.